Thread: PET/CT vs CT
View Single Post
Old 06-08-2009, 07:03 PM   #8
Joan M
Senior Member
 
Joan M's Avatar
 
Join Date: Oct 2007
Posts: 1,851
Richie,

As Chrisy noted, the PET looks only at metabolic activity. That is, it measures glucose metabolism.

Cancer cells take in large amounts of glucose.

The PET scan show a signal by lighting up on the scan. Anything over the standard uptake value (SUV) 3.0 is considered suspicious for cancer, but other things can light up, like tuberculous or infection. For example, in my case, the lightening up in the lung of my PET/CT in January now seems related to infection (hence the aspergillioma and coughing up blood, etc.).

Also, there was no correlation on CT. That is, even though the PET was lighting up at levels as high as 6.0 (which didn't even happen when the cancer nodules lit up), the CT scan did not show any morphological correlation as in something looking like a nodule. CT scans show morphology, as Chrisy noted. The attenuation part has to do with lining up the patient to give the PET signals a more specific location on a map.

A PET/CT is bascially a PET scan in that the patient is given a radioactive isotope (FDG 18). Sometimes the patient is also given a contrast medium to drink for the CT part, but that's just to get a better map of the abdomen and pelvis area.

The patient is given the isotope first and made to sit in the "guiet room" in the near dark for about an hour (I remember at first thinking, What the hell is the "quiet room."). They don't even want you to read or move a muscle. If you move muscles around a lot the isotope accumulates in those areas of the body and could light up a false positive.

During the scan, the patient is first put through the machine quickly a few times. That's the CT attenuation, correlation part. Then they start the PET part, which is slower.

Also, since PET scans measure metabolic activity, they're not used to scan the brain for cancer.

Joan
__________________
Diagnosed stage 2b in July 2003 (2.3 cm, HER2+, ER-/PR-, 7+ nodes). Treated with mastectomy (with immediate DIEP flap reconstruction), AC + T/Herceptin (off label). Cancer advanced to lung in Jan. 2007 (1 cm nodule). Started Herceptin every 3 weeks. Lung wedge resection April 2007. Cancer recurred in lung April 2008. RFA of lung in August 2008. 2nd annual brain MRI in Oct. 2008 discovered 2.6 cm cystic tumor in left frontal lobe. Craniotomy Oct. 2008 (ER-/PR-/HER2-) followed by targeted radiation (IMRT). Coughing up blood Feb. 2009. Thoractomy July 2009 to cut out fungal ball of common soil fungus (aspergillus) that grew in the RFA cavity (most likely inhaled while gardening). No cancer, only fungus. Removal of tiny melanoma from upper left arm, plus sentinel lymph node biopsy in Feb. 2016. Guardant Health liquid biopsy in Feb. 2016 showed mutations in 4 subtypes of TP53. Repeat of Guardant Health biopsy in Jana. 2021 showed 3 TP53 mutations, BRCA1 mutation and CHEK2 mutation. Invitae genetic testing showed negative for all of these. Living with MBC since 2007. Stopped Herceptin Hylecta (injection) treatment in March 2020. Recent 2021 annual CT of chest, abdomen and pelvis and annual brain MRI showed NED. Praying for NED forever!!
Joan M is offline   Reply With Quote